Publikationen in Zusammenarbeit mit Forschern von Hospital Infanta Leonor (27)

2024

  1. Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitter

    Journal of Affective Disorders, Vol. 351, pp. 649-660

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Predicting bipolar disorder I/II in individuals at clinical high-risk: Results from a systematic review

    Journal of Affective Disorders, Vol. 325, pp. 778-786

2022

  1. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  2. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  3. Long-term outcomes among a nationwide cohort of patients using an implantable cardioverter-defibrillator: UMBRELLA study final results

    Journal of the American Heart Association, Vol. 10, Núm. 1, pp. 1-23

  4. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  5. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

  6. R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

    Cancer Medicine, Vol. 10, Núm. 4, pp. 1314-1326

  7. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. Patient satisfaction with remote monitoring of cardiac implantable electronic devices: The Valiosa questionnaire

    BMC Health Services Research, Vol. 20, Núm. 1

  3. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy

    ESC Heart Failure, Vol. 7, Núm. 1, pp. 279-283

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  2. Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015)

    Contact Dermatitis, Vol. 80, Núm. 2, pp. 94-100

  3. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices

    Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275

  4. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis

    International Journal of Cardiology, Vol. 274, pp. 163-169

2018

  1. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

    Journal of Thrombosis and Thrombolysis, Vol. 46, Núm. 4, pp. 551-558